Chris Fanale
Corporate Officer/Principal bei Tremeau Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Chris Fanale
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Chris Fanale
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Alladapt Immunotherapeutics, Inc.
 Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alladapt Immunotherapeutics, Inc. operates as a biopharmaceutical company developing prescription therapeutics targeting food allergy. The company was founded by Ashley Dombkowski and Kari Nadeau in 2018 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
Corium LLC
 Corium LLC BiotechnologyHealth Technology Corium LLC is a commercial-stage biopharmaceutical company that specializes in developing and commercializing novel neuroscience therapies. Corium is based in Grand Rapid, MI, and the CEO of the private company is Perry J. Sternberg. The company provides clinicians with important treatment options for patients, their families, and their caregivers. | Biotechnology | Director/Board Member | |
Crossover Health, Inc.
 Crossover Health, Inc. Medical/Nursing ServicesHealth Services Crossover Health, Inc. provides worksite health and wellness services. It offers primary, ancillary, and advanced services, includes urgent care, occupational health, preventive care, chronic disease management, health risk assessment, health education, health coaching, biometrics, physical therapy, chiropractic, acupuncture, specialist preferred network, care coordination, health analytics, and remote care. The company was founded by Scott Shreeve in 2010 and is headquartered in Aliso Viejo, CA. | Medical/Nursing Services | Director/Board Member | |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Wisconsin | College/University | Graduate Degree | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Lehigh University | College/University | Masters Business Admin | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
| Tranzyme Pharma, Inc. (Canada) | Corporate Officer/Principal | ||
| SIRONA BIOCHEM CORP. | Pharmaceuticals: Major | Director/Board Member | |
| Towson University | College/University | Undergraduate Degree | |
| Thomas Jefferson University | College/University | Undergraduate Degree | |
Lennham Pharmaceuticals, Inc.
 Lennham Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lennham Pharmaceuticals, Inc. develops pharmaceutical products. The CEO of the American company is Bradford C. Sippy. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 17 |
| Kanada | 3 |
Sektoral
| Health Technology | 11 |
| Consumer Services | 5 |
| Finance | 2 |
| Health Services | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 14 |
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 3 |
| Chief Executive Officer | 3 |
| Private Equity Investor | 2 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| David S. Moore | 13 |
| Travis Wilson | 9 |
| Bradford C. Sippy | 2 |
| Travis Helm | 1 |
| James Singleton | 1 |
- Börse
- Insiders
- Chris Fanale
- Unternehmensverbindungen
